Heather Monk Bodenstab, PharmD

Residency

Pharmacy Practice (PGY1) and Pediatric Specialty (PGY2) - The Children's Hospital of Philadelphia, Philadelphia, PA

Board Certification

Pediatric Advanced Life Support (PALS)

Graduate Degree

PharmD - West Virginia University School of Pharmacy, Morgantown, WV

Papers

2018

Luo J, Shepard S, Nilan K, Wood A,  Monk HM, Jensen EA, Harrington AT,  Maschhoff K, Kirpalani H, Feng Z,  Zhang H. Improved growth and developmental activity post tracheostomy in preterm infants with severe BPD. Pediatr Pulmonol. 2018 Jul 3. doi: 10.1002/ppul.24087. [Epub ahead of print]

Lawrence KM, Hedrick HL, Monk HM, Herkert L, Waqar LN, Hanna BD, Peranteau WH, Rintoul NE, Hopper RK. Treprostinil Improves Persistent Pulmonary Hypertension Associated with Congenital Diaphragmatic Hernia. J Pediatr. 2018 May 18. [Epub ahead of print] PMID: 29784517 

2016

Jensen EA, White AM, Liu P, Yee K, Waber B, Monk HM, Zhang H. Determinants of severe metabolic bone disease in very low-birth-weight infants with severe bronchopulmonary dysplasia admitted to a tertiary referral center. Am J Perinatol. 2016;33(1):1011-7.

2015

Wade KC and Monk HM. New antifungal and antiviral dosing. Clin Perinatol. 2015;42:177-194.

George S, Weber D, Kaplan P, Hummel K, Monk HM, Levine MA. Short Term Safety of Zoledronic Acid in Young Patients with Bone Disorders: An Extensive Institutional Experience. J Clin Endocrinol Metab. 2015 Aug 26:jc20152680. [Epub ahead of print].

Jensen EA, White AM, Liu P, Yee K, Waber B, Monk HM, Zhang H. Determinants of Severe Metabolic Bone Disease in VLBW Infants with Severe Bronchopulmonary Dysplasia Admitted to a Tertiary Referral Center. Am J Perinatol 2015.[Epub ahead of print].

Rustico SE, Kelly A, Monk HM, Calabria AC. Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: A preliminary study. J Clin Trans Endocrinol. 2015; 2: 15-20.

2014

Monk Bodenstab H, Motsney AJ, Wade KC. Safety of rotavirus vaccine in the NICU. Pediatrics. 2014 Jun;133(6):e1555-60.

McIntyre CM, Monk Bodenstab H. Medication absorption considerations in patients with postpyloric enteral feeding tubes. Am J Health Syst Pharm. 2014 Apr 1;71(7):549-56.

Gannon AW, Monk Bodenstab H, Levine MA. Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review. J Clin Endocrinol Metab. 2014 Jan;99(1):7-11.

2013

Sullivan KM, Suh S, Monk HM, Chuo J. Personalised performance feedback reduces narcotic prescription errors in a NICU. BMJ Qual Saf. 2013 Mar;22(3):256-62. Epub 2012 Oct 4.

2011

Abend NS, Guiterrez-Colina AcM, Monk HM, Dlugos DJ, Clancy RR. Levetiracetam for treatment of neonatal seizures. J Child Neurol. 2011 Apr;26(4):465-70. Epub 2011 Jan 13. Cited in PubMed: PMID 21233461.

2009

Abend NS, Monk HM, Licht DJ, Dlugos DJ. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures. Pediatr Crit Care Med. 2009 Jul;10(4):505-10. Cited in PubMed: PMID 19325512.

Posters and Presentations

2018

Luo J, Shepard S, Nilan K, Wood A, Monk HM, Jensen EA, Harrington AT, Maschhoff K, Kirpalani H, Feng Z, Zhang H. Improved growth and developmental activity post tracheostomy in preterm infants with severe BPD. Pediatr Pulmonol. 2018 Jul 3. doi: 10.1002/ppul.24087. [Epub ahead of print]

Bamat NA, Kirpalani H, Feudtner C, Jensen EA, Laughon M, Zhang H, Monk HM, Passarella M, Lorch S. Medication Use and Polypharmacy in Infants with Severe Bronchopulmonary Dysplasia Admitted to United States Children’s Hospitals. Poster presentation at the Eastern Society for Pediatric Research Annual Meeting, Philadelphia, PA, March 2018.

2016

Franciscovish CD, Monk HM, Ely E. Sedation Practices of Neonates Receiving Extracorporeal Membrane Oxygenation [Poster Presentation]. 27TH Annual Extracorporeal Life Support Organization Conference, San Diego, CA. September 2016.

Hoffman ML, Monk HM, Rintoul N, Dysart K, James J, Williams S, Connelly J. Characterization or Hypertension Management Strategies in Neonates Requiring ECMO Support [Poster Presentation]. 27TH Annual Extracorporeal Life Support Organization Conference, San Diego, CA. September 2016.

Waber B, Jensen EA, Liu P, White A, Yee K, Monk HM, Zhang H. Postnatal corticosteroids and surgical necrotizing enterocolitis increase metabolic bone disease risk in infants with severe bronchopulmonary dysplasia [poster presentation]. CHOP Research poster days, February 2015, Philadelphia, PA.

2014

Zanno A, Ades A, Rintoul N, Collins J, Williams S, Connelly, J, Monk HM. A Neonate with Disseminated Candidiasis Treated with ECMO [poster presentation]. 25th Annual Extracorporeal Life Support Organization Conference, Ann Arbor, MI (September 2014)

Ebbert RP, Monk HM, Hedrick HL, Rintoul N, Connelly J, Maschhoff K. 2-Year Review of Dexamethasone use in Congenital Diaphragmatic Hernia Patients During ECMO Support. Poster Presentation at the 25th Annual Extracorporeal Life Support Organization Conference, Ann Arbor, MI (September 2014)

George S, Weber D, Monk HM, Hummel K, Kaplan P, Ganesh J, Levine M. Assessment of adverse events associated with zoledronic acid use in children and young adults with metabolic and genetic bone disease. Platform Presentation at the American Society for Bone Mineral Research Conference, Houston, TX (June 2014)

2011

Betts PA, Monk Bodenstab H. A Retrospective Evaluation of Causative Pathogens and Antibiotic Prescribing Practices in Necrotizing Enterocolitis [platform presentation]. Eastern State Residency Conference; May 2011, Hershey, PA.